Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-05-03
1998-09-01
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530380, 530324, 530300, A61K 3800, A61K 3514
Patent
active
058011463
ABSTRACT:
Mammalian kringle 5 is disclosed as a compound for treating angiogenic diseases. Methods and compositions for inhibiting angiogenic diseases are also disclosed.
REFERENCES:
patent: 5639725 (1997-06-01), O'Reilley et al.
Scrip 2120:21 (Apr. 16, 1996).
Fidler, I.J., et al., "The Implications of Angiogenesis for the Biology and Therapy of Cancer Metastasis", Cell, 79:185-188 (1994).
Folkman, J., "Clinical Applications of Research on Angiongenesis", The New England Journal of Medicine, 333(26):1757-1763 (1995).
Folkman, J., et al., "Angiogenesis", Journ. of Biological Chemistry, 267(16):10931-10934 (1992).
Folkman, J., et al., "Angiogenic Factors", Science, 235:442-447 (1987).
Gasparini, G., et al., "Clinical Importance of the Determination of Tumor Angiogenesis in Breast Carcinoma: Much More Than a New Prognostic Tool", Journ. of Clinical Oncology, 13(3):765-782 (1995).
Sottrup-Jensen, L., et al., "The Primary Structure of Human Plasminogen: Isolation of Two Lysine-Binding Fragments and One Mini-Plasminogen (MW, 38,000) by Elastase-Catalyzed-Specific Limited Proteolysis", Progress in Chemical Fibrinolysis and Thrombolysis, 3:191-209 (1978).
Kolberg, R., "Angogenic Inhibitor Loss May Be Key To Post-Surgery Metastasis", Journal of NIH Research, 8:31-33 (1994).
Menhart, N., et al., "Functional Independence of the Kringle 4 and Kringle 5 Regions of Human Plasminogen", Biochemistry, 32:8799-8806 (1993).
Novokhatny, V. V., et al., "Domains in Human Plasminogen", J, Mol. Biol., 179:215-232 (1984).
O'Reilly, M. S., et al., "Angiostatin: A Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma", Cell, 79:315-328 (1994).
Teicher, B. A., et al., "Antiangiogenic Agents Can Increase Tumor Oxygenation and Response to Radiation Therapy", Radiation Oncology Investigations, 2:269-276 (1995).
Teicher, B. A., et al., "Antiangiogenic Agents Potentiate Cytotoxic Cancer Therapies against Primary and Metastatic Disease", Cancer Research, 52:6702-6704 (1992).
Teicher, B. A., et al., "Antiangiogenic Treatment (TNP-470/Minocycline) Increase Tissue Levels of Anticancer Drugs in Mice Bearing Lewis Lung Carcinoma", Oncology Research, 7(5):237-243 (1995).
Teicher, B. A., et al., ".beta.-Cyclodextrin tetradecasulfate/tetrahydrocortisol .+-. minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic lewis lung carcinoma", Cancer Chemother Pharmacol, 33:229-239 (1993).
Teicher, B. A., et al., "Influence of an Anti-Angiogenic Treatment on 9L Gliosarcoma: Oxygenation and Response ot Cytotoxic Therapy", Int. J. Cancer, 61:732-737 (1995).
Teicher, B. A., et al., "Potentiation of Cytotoxic Cancer Therapies by TNP-470 Alone and With Other Anti-Angiogenic Agents", Int. J. Cancer, 57:920-925 (1994).
Teicher, B. A., et al., "Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma ", Breast Cancer Research and Treatment, 36:227-236 (1995).
Thewest, T., et al., "Ligand Interactions with the Kringle 5 Domain of Plasminogen", Journal of Biological Chemistry, 265(7):3906-3915 (1990).
Weidner, N., et al., "Tumor Angiogensis and Metastasis--Correlation in Invasive Breast Carcinoma", The New England Journal of Medicine, 324(1):1-8 (1991).
Thewes et al. (Apr. 8, 1987) Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen. Biochimica et Biophysica Acta 912(2): 254-269.
Varadi et al. (Nov. 16, 1981) Kringle 5 of human plasminogen carries a benzamidine-binding site. Biochem. Biophys. Res. Commun. 103(1): 97-102.
McCance et al. (Dec. 23, 1994) Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with w-amino acid ligands. J. Biol. Chem 269(51): 32405-32410.
Abbott Laboratories
Casuto Dianne
Steele Gregory W.
Stole Einar
Wax Robert A.
LandOfFree
Compound and method for inhibiting angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compound and method for inhibiting angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound and method for inhibiting angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270252